Outpatient Treatment of Severe and Enduring Anorexia Nervosa

Completed

• Conditions: Anorexia

• Registration Number: NCT05708404
• Lead Sponsor: Helsinki University Central Hospital

Brief Summary

Approximately 20-30 % of individuals with the eating disorder anorexia nervosa develop an enduring form of the illness. In this study a new treatment for patients with severe and enduring anorexia nervosa was described. The treatment is flexible and aims at enhancing quality of life. The participants consisted of all referrals resulting in an assessment or treatment period at the unit between May 2017 and May 2022. The study was a registry study. Information regarding patient characteristics, treatment goals, and the course of treatment was gathered from medical records.

Detailed Description

Not available

Study Timeline

• Study Start: 2017-05-01
• Primary Completion: 2022-05-31
• Study Completion: 2022-05-31
• Status Verified: 2023-01
• Study First Submitted: 2023-01-11
• Study First Submitted QC: 2023-01-23
• Last Update Submitted: 2023-01-23
• Study First Posted: 2023-02-01
• Last Update Posted: 2023-02-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
How the treatment goals were met	At the end of treatment, an average of 15.4 months	Whether or not the patients' individual treatment goals, defined at the beginning of treatment, had been met, partly met, or not met at the end of treatment.

Trial Locations

Locations (1)

HUS Syömishäiriöyksikkö; 🇫🇮 Helsinki, Pl 282, Finland